Biosynex Logo

Biosynex

Designs and distributes medical diagnostic solutions, including rapid tests and devices.

ALBIO | PA

Overview

Corporate Details

ISIN(s):
FR0011005933
LEI:
969500H4BGE1HBLGP566
Country:
France
Address:
22 BOULEVARD SEBASTIEN BRANT, 67400 ILLKIRCH-GRAFFENSTADEN

Description

Biosynex is a company that specializes in the design, manufacture, and distribution of medical diagnostic solutions. Its core product line consists of Rapid Diagnostic Tests (RDTs) for both professional use in clinical settings and for self-testing by the general public. The professional portfolio includes point-of-care (POC) instruments, molecular biology diagnostics (such as PCR tests), and a wide array of immunodiagnostic assays. For the consumer market, Biosynex offers various self-tests and a range of prevention and monitoring devices, including thermometers, blood pressure monitors, and pulse oximeters. The company focuses on providing simple, rapid, and effective tools for screening, diagnosis, and prevention.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-04-07 18:46
BIOSYNEX SA: POURSUITE D'UNE ACTIVITE DYNAMIQUE AU T1 2022
French 432.0 KB
2022-04-04 18:00
BIOSYNEX SA: DECLARATION DU NOMBRE D'ACTIONS ET DES DROITS DE VOTE AU 31 MARS …
French 286.7 KB
2022-03-30 18:00
BIOSYNEX SA: OFFRE FERME PORTANT SUR L'ACHAT DE LA MARQUE PARAKITO, DE SES ACTI…
French 413.2 KB
2022-03-24 18:14
BIOSYNEX SA: RESULTATS ANNUELS 2021 EN FORTE HAUSSE
French 544.2 KB
2022-03-15 08:50
BIOSYNEX SA: DECLARATION DU NOMBRE D'ACTIONS ET DES DROITS DE VOTE AU 28 FEVRI…
French 191.0 KB
2022-03-01 18:28
BIOSYNEX SA: SUIVI DES ACTIONS ACHETEES DANS LE CADRE DU PROGRAMME DE RACHAT D'…
French 236.1 KB
2022-01-20 18:00
BIOSYNEX SA: MULTIPLICATION PAR 2,5 DU CHIFFRE D'AFFAIRES 2021 A 383 M€
French 251.1 KB
2022-01-13 07:30
BIOSYNEX SA: SIGNATURE AVEC THERADIAG D'UN CONTRAT DE DISTRIBUTION DU TEST PCR…
French 616.7 KB
2022-01-04 18:00
BIOSYNEX SA: DECLARATION DU NOMBRE D'ACTIONS ET DES DROITS DE VOTE AU 31 DECEM…
French 192.7 KB
2022-01-03 18:00
BIOSYNEX SA: BIOSYNEX ANNONCE LA FINALISATION DE L'ACQUISITION DE LA BRANCHE SA…
French 277.1 KB
2021-12-30 17:45
BIOSYNEX SA: FIN DE LA PÉRIODE D'EXERCICE DES BSAR: 3,78 M€ LEVES
French 280.0 KB
2021-12-23 18:07
BIOSYNEX SA: SUIVI DES ACTIONS ACHETEES DANS LE CADRE DU PROGRAMME DE RACHAT D'…
French 405.4 KB
2021-12-16 17:45
BIOSYNEX SA: SUIVI DES ACTIONS ACHETEES DANS LE CADRE DU PROGRAMME DE RACHAT D'…
French 222.1 KB
2021-12-09 18:31
BIOSYNEX SA: BIOSYNEX ANNONCE SON AGENDA FINANCIER 2022
French 270.2 KB
2021-12-06 18:00
BIOSYNEX SA: LE TEST RT-PCR BIOSYNEX AMPLIQUICK(R) SARS-COV-2 DETECTE UN DES PR…
French 273.6 KB

Automate Your Workflow. Get a real-time feed of all Biosynex filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Biosynex

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Biosynex via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.